NCT02893423View on ClinicalTrials.gov

Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia

NATerminatedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

January 1, 2013

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Postoperative Pain
Interventions
DRUG

Ropivacaine

Using 2 Different Concentrations of Ropivacaine in Tap Block for Postoperative Analgesia for C-Section Patients

Trial Locations (1)

11219

Maimonides Medical Center, Brooklyn

Sponsors
All Listed Sponsors
lead

Maimonides Medical Center

OTHER

NCT02893423 - Ropivacaine Transversus Abdominis Plane Blocks for Cesarean Section Analgesia | Biotech Hunter | Biotech Hunter